aluates Reports

$ 0.0

Automative

Hydroxycarbamide- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031

Published Date: August 2025

Report Code: QYRE-Auto-39J9030

Global Hydroxycarbamide Market Insights and Forecast to 2028

BUY CHAPTERS

Hydroxycarbamide- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031

Code: QYRE-Auto-39J9030

Report

August 2025

Pages:125

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Bristol–Myers Squibb

Taj Pharma

Beijing Jialin Pharma

Qilu Pharmaceutical

Teva Pharma

Cipla Ltd

Zydus Cadila

United Biotech

Par Pharma

Khandelwal Laboratories

Alkem (Cytomed)

Samarth Pharma

VHB Life Sciences

Hydroxycarbamide- Market Size

The global market for Hydroxycarbamide was estimated to be worth US$ 260 million in 2024 and is forecast to a readjusted size of US$ 378 million by 2031 with a CAGR of 5.6% during the forecast period 2025-2031.

Hydroxycarbamide- Market

Hydroxycarbamide, also known as hydroxyurea, is a medication used in sickle-cell disease, chronic myelogenous leukemia, cervical cancer, and polycythemia vera. In sickle-cell disease it decreases the number of attacks. It is taken by mouth.

Common side effects include bone marrow suppression, fevers, loss of appetite, psychiatric problems, shortness of breath, and headaches. There is also concern that it increases the risk of later cancers. Use during pregnancy is typically harmful to the baby. Hydroxycarbamide is in the antineoplastic family of medications. It is believed to work by blocking the making of DNA.

Global Hydroxycarbamide key players include Qilu Pharmaceutical, Beijing Jialin Pharma, Taj Pharma, etc. Global top three manufacturers hold a share over 35%.

Asia-Pacific is the largest market, with a share nearly 60%, followed by Europe, and North America, both have a share about 40 percent.

In terms of product, Capsule is the largest segment, with a share over 60%. And in terms of application, the largest application is Sickle Cell Disease, followed by Cancer, etc.

This report aims to provide a comprehensive presentation of the global market for Hydroxycarbamide, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Hydroxycarbamide by region & country, by Type, and by Application.

The Hydroxycarbamide market size, estimations, and forecasts are provided in terms of sales volume (M Units) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hydroxycarbamide.

Market Segmentation

Scope of Hydroxycarbamide- Market Report

Report Metric	Details
Report Name	Hydroxycarbamide- Market
Forecasted market size in 2031	US$ 378 million
CAGR	5.6%
Forecasted years	2025 - 2031
Segment by Type	Capsule Tablet
Segment by Application	Sickle Cell Disease Cancer Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Bristol Myers Squibb, Taj Pharma, Beijing Jialin Pharma, Qilu Pharmaceutical, Teva Pharma, Cipla, Zydus Cadila, United Biotech, Par Pharma, Khandelwal Laboratories, Alkem (Cytomed), Samarth Pharma, VHB Life Sciences
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Hydroxycarbamide manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Hydroxycarbamide in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Hydroxycarbamide in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

FAQ for this report

What is the Hydroxycarbamide- Market size in 2031?

Ans: The Hydroxycarbamide- Market size in 2031 will be US$ 378 million.

What is the market share of major companies in Hydroxycarbamide- Market?

Ans: Global top three manufacturers hold a share over 35%.

What is the Hydroxycarbamide- Market share by type?

Ans: In terms of product, Capsule is the largest segment, with a share over 60%.

Who are the main players in the Hydroxycarbamide- Market report?

Ans: The main players in the Hydroxycarbamide- Market are Bristol Myers Squibb, Taj Pharma, Beijing Jialin Pharma, Qilu Pharmaceutical, Teva Pharma, Cipla, Zydus Cadila, United Biotech, Par Pharma, Khandelwal Laboratories, Alkem (Cytomed), Samarth Pharma, VHB Life Sciences

What are the Application segmentation covered in the Hydroxycarbamide- Market report?

Ans: The Applications covered in the Hydroxycarbamide- Market report are Sickle Cell Disease, Cancer, Others

What are the Type segmentation covered in the Hydroxycarbamide- Market report?

Ans: The Types covered in the Hydroxycarbamide- Market report are Capsule, Tablet

1 Market Overview

1.1 Hydroxycarbamide Product Introduction

1.2 Global Hydroxycarbamide Market Size Forecast

1.2.1 Global Hydroxycarbamide Sales Value (2020-2031)

1.2.2 Global Hydroxycarbamide Sales Volume (2020-2031)

1.2.3 Global Hydroxycarbamide Sales Price (2020-2031)

1.3 Hydroxycarbamide Market Trends & Drivers

1.3.1 Hydroxycarbamide Industry Trends

1.3.2 Hydroxycarbamide Market Drivers & Opportunity

1.3.3 Hydroxycarbamide Market Challenges

1.3.4 Hydroxycarbamide Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Hydroxycarbamide Players Revenue Ranking (2024)

2.2 Global Hydroxycarbamide Revenue by Company (2020-2025)

2.3 Global Hydroxycarbamide Players Sales Volume Ranking (2024)

2.4 Global Hydroxycarbamide Sales Volume by Company Players (2020-2025)

2.5 Global Hydroxycarbamide Average Price by Company (2020-2025)

2.6 Key Manufacturers Hydroxycarbamide Manufacturing Base and Headquarters

2.7 Key Manufacturers Hydroxycarbamide Product Offered

2.8 Key Manufacturers Time to Begin Mass Production of Hydroxycarbamide

2.9 Hydroxycarbamide Market Competitive Analysis

2.9.1 Hydroxycarbamide Market Concentration Rate (2020-2025)

2.9.2 Global 5 and 10 Largest Manufacturers by Hydroxycarbamide Revenue in 2024

2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hydroxycarbamide as of 2024)

2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type

3.1 Introduction by Type

3.1.1 Capsule

3.1.2 Tablet

3.2 Global Hydroxycarbamide Sales Value by Type

3.2.1 Global Hydroxycarbamide Sales Value by Type (2020 VS 2024 VS 2031)

3.2.2 Global Hydroxycarbamide Sales Value, by Type (2020-2031)

3.2.3 Global Hydroxycarbamide Sales Value, by Type (%) (2020-2031)

3.3 Global Hydroxycarbamide Sales Volume by Type

3.3.1 Global Hydroxycarbamide Sales Volume by Type (2020 VS 2024 VS 2031)

3.3.2 Global Hydroxycarbamide Sales Volume, by Type (2020-2031)

3.3.3 Global Hydroxycarbamide Sales Volume, by Type (%) (2020-2031)

3.4 Global Hydroxycarbamide Average Price by Type (2020-2031)

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Sickle Cell Disease

4.1.2 Cancer

4.1.3 Others

4.2 Global Hydroxycarbamide Sales Value by Application

4.2.1 Global Hydroxycarbamide Sales Value by Application (2020 VS 2024 VS 2031)

4.2.2 Global Hydroxycarbamide Sales Value, by Application (2020-2031)

4.2.3 Global Hydroxycarbamide Sales Value, by Application (%) (2020-2031)

4.3 Global Hydroxycarbamide Sales Volume by Application

4.3.1 Global Hydroxycarbamide Sales Volume by Application (2020 VS 2024 VS 2031)

4.3.2 Global Hydroxycarbamide Sales Volume, by Application (2020-2031)

4.3.3 Global Hydroxycarbamide Sales Volume, by Application (%) (2020-2031)

4.4 Global Hydroxycarbamide Average Price by Application (2020-2031)

5 Segmentation by Region

5.1 Global Hydroxycarbamide Sales Value by Region

5.1.1 Global Hydroxycarbamide Sales Value by Region: 2020 VS 2024 VS 2031

5.1.2 Global Hydroxycarbamide Sales Value by Region (2020-2025)

5.1.3 Global Hydroxycarbamide Sales Value by Region (2026-2031)

5.1.4 Global Hydroxycarbamide Sales Value by Region (%), (2020-2031)

5.2 Global Hydroxycarbamide Sales Volume by Region

5.2.1 Global Hydroxycarbamide Sales Volume by Region: 2020 VS 2024 VS 2031

5.2.2 Global Hydroxycarbamide Sales Volume by Region (2020-2025)

5.2.3 Global Hydroxycarbamide Sales Volume by Region (2026-2031)

5.2.4 Global Hydroxycarbamide Sales Volume by Region (%), (2020-2031)

5.3 Global Hydroxycarbamide Average Price by Region (2020-2031)

5.4 North America

5.4.1 North America Hydroxycarbamide Sales Value, 2020-2031

5.4.2 North America Hydroxycarbamide Sales Value by Country (%), 2024 VS 2031

5.5 Europe

5.5.1 Europe Hydroxycarbamide Sales Value, 2020-2031

5.5.2 Europe Hydroxycarbamide Sales Value by Country (%), 2024 VS 2031

5.6 Asia Pacific

5.6.1 Asia Pacific Hydroxycarbamide Sales Value, 2020-2031

5.6.2 Asia Pacific Hydroxycarbamide Sales Value by Region (%), 2024 VS 2031

5.7 South America

5.7.1 South America Hydroxycarbamide Sales Value, 2020-2031

5.7.2 South America Hydroxycarbamide Sales Value by Country (%), 2024 VS 2031

5.8 Middle East & Africa

5.8.1 Middle East & Africa Hydroxycarbamide Sales Value, 2020-2031

5.8.2 Middle East & Africa Hydroxycarbamide Sales Value by Country (%), 2024 VS 2031

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Hydroxycarbamide Sales Value Growth Trends, 2020 VS 2024 VS 2031

6.2 Key Countries/Regions Hydroxycarbamide Sales Value

6.2.1 Key Countries/Regions Hydroxycarbamide Sales Value, 2020-2031

6.2.2 Key Countries/Regions Hydroxycarbamide Sales Volume, 2020-2031

6.3 United States

6.3.1 United States Hydroxycarbamide Sales Value, 2020-2031

6.3.2 United States Hydroxycarbamide Sales Value by Type (%), 2024 VS 2031

6.3.3 United States Hydroxycarbamide Sales Value by Application, 2024 VS 2031

6.4 Europe

6.4.1 Europe Hydroxycarbamide Sales Value, 2020-2031

6.4.2 Europe Hydroxycarbamide Sales Value by Type (%), 2024 VS 2031

6.4.3 Europe Hydroxycarbamide Sales Value by Application, 2024 VS 2031

6.5 China

6.5.1 China Hydroxycarbamide Sales Value, 2020-2031

6.5.2 China Hydroxycarbamide Sales Value by Type (%), 2024 VS 2031

6.5.3 China Hydroxycarbamide Sales Value by Application, 2024 VS 2031

6.6 Japan

6.6.1 Japan Hydroxycarbamide Sales Value, 2020-2031

6.6.2 Japan Hydroxycarbamide Sales Value by Type (%), 2024 VS 2031

6.6.3 Japan Hydroxycarbamide Sales Value by Application, 2024 VS 2031

6.7 South Korea

6.7.1 South Korea Hydroxycarbamide Sales Value, 2020-2031

6.7.2 South Korea Hydroxycarbamide Sales Value by Type (%), 2024 VS 2031

6.7.3 South Korea Hydroxycarbamide Sales Value by Application, 2024 VS 2031

6.8 Southeast Asia

6.8.1 Southeast Asia Hydroxycarbamide Sales Value, 2020-2031

6.8.2 Southeast Asia Hydroxycarbamide Sales Value by Type (%), 2024 VS 2031

6.8.3 Southeast Asia Hydroxycarbamide Sales Value by Application, 2024 VS 2031

6.9 India

6.9.1 India Hydroxycarbamide Sales Value, 2020-2031

6.9.2 India Hydroxycarbamide Sales Value by Type (%), 2024 VS 2031

6.9.3 India Hydroxycarbamide Sales Value by Application, 2024 VS 2031

7 Company Profiles

7.1 Bristol Myers Squibb

7.1.1 Bristol Myers Squibb Company Information

7.1.2 Bristol Myers Squibb Introduction and Business Overview

7.1.3 Bristol Myers Squibb Hydroxycarbamide Sales, Revenue, Price and Gross Margin (2020-2025)

7.1.4 Bristol Myers Squibb Hydroxycarbamide Product Offerings

7.1.5 Bristol Myers Squibb Recent Development

7.2 Taj Pharma

7.2.1 Taj Pharma Company Information

7.2.2 Taj Pharma Introduction and Business Overview

7.2.3 Taj Pharma Hydroxycarbamide Sales, Revenue, Price and Gross Margin (2020-2025)

7.2.4 Taj Pharma Hydroxycarbamide Product Offerings

7.2.5 Taj Pharma Recent Development

7.3 Beijing Jialin Pharma

7.3.1 Beijing Jialin Pharma Company Information

7.3.2 Beijing Jialin Pharma Introduction and Business Overview

7.3.3 Beijing Jialin Pharma Hydroxycarbamide Sales, Revenue, Price and Gross Margin (2020-2025)

7.3.4 Beijing Jialin Pharma Hydroxycarbamide Product Offerings

7.3.5 Beijing Jialin Pharma Recent Development

7.4 Qilu Pharmaceutical

7.4.1 Qilu Pharmaceutical Company Information

7.4.2 Qilu Pharmaceutical Introduction and Business Overview

7.4.3 Qilu Pharmaceutical Hydroxycarbamide Sales, Revenue, Price and Gross Margin (2020-2025)

7.4.4 Qilu Pharmaceutical Hydroxycarbamide Product Offerings

7.4.5 Qilu Pharmaceutical Recent Development

7.5 Teva Pharma

7.5.1 Teva Pharma Company Information

7.5.2 Teva Pharma Introduction and Business Overview

7.5.3 Teva Pharma Hydroxycarbamide Sales, Revenue, Price and Gross Margin (2020-2025)

7.5.4 Teva Pharma Hydroxycarbamide Product Offerings

7.5.5 Teva Pharma Recent Development

7.6 Cipla

7.6.1 Cipla Company Information

7.6.2 Cipla Introduction and Business Overview

7.6.3 Cipla Hydroxycarbamide Sales, Revenue, Price and Gross Margin (2020-2025)

7.6.4 Cipla Hydroxycarbamide Product Offerings

7.6.5 Cipla Recent Development

7.7 Zydus Cadila

7.7.1 Zydus Cadila Company Information

7.7.2 Zydus Cadila Introduction and Business Overview

7.7.3 Zydus Cadila Hydroxycarbamide Sales, Revenue, Price and Gross Margin (2020-2025)

7.7.4 Zydus Cadila Hydroxycarbamide Product Offerings

7.7.5 Zydus Cadila Recent Development

7.8 United Biotech

7.8.1 United Biotech Company Information

7.8.2 United Biotech Introduction and Business Overview

7.8.3 United Biotech Hydroxycarbamide Sales, Revenue, Price and Gross Margin (2020-2025)

7.8.4 United Biotech Hydroxycarbamide Product Offerings

7.8.5 United Biotech Recent Development

7.9 Par Pharma

7.9.1 Par Pharma Company Information

7.9.2 Par Pharma Introduction and Business Overview

7.9.3 Par Pharma Hydroxycarbamide Sales, Revenue, Price and Gross Margin (2020-2025)

7.9.4 Par Pharma Hydroxycarbamide Product Offerings

7.9.5 Par Pharma Recent Development

7.10 Khandelwal Laboratories

7.10.1 Khandelwal Laboratories Company Information

7.10.2 Khandelwal Laboratories Introduction and Business Overview

7.10.3 Khandelwal Laboratories Hydroxycarbamide Sales, Revenue, Price and Gross Margin (2020-2025)

7.10.4 Khandelwal Laboratories Hydroxycarbamide Product Offerings

7.10.5 Khandelwal Laboratories Recent Development

7.11 Alkem (Cytomed)

7.11.1 Alkem (Cytomed) Company Information

7.11.2 Alkem (Cytomed) Introduction and Business Overview

7.11.3 Alkem (Cytomed) Hydroxycarbamide Sales, Revenue, Price and Gross Margin (2020-2025)

7.11.4 Alkem (Cytomed) Hydroxycarbamide Product Offerings

7.11.5 Alkem (Cytomed) Recent Development

7.12 Samarth Pharma

7.12.1 Samarth Pharma Company Information

7.12.2 Samarth Pharma Introduction and Business Overview

7.12.3 Samarth Pharma Hydroxycarbamide Sales, Revenue, Price and Gross Margin (2020-2025)

7.12.4 Samarth Pharma Hydroxycarbamide Product Offerings

7.12.5 Samarth Pharma Recent Development

7.13 VHB Life Sciences

7.13.1 VHB Life Sciences Company Information

7.13.2 VHB Life Sciences Introduction and Business Overview

7.13.3 VHB Life Sciences Hydroxycarbamide Sales, Revenue, Price and Gross Margin (2020-2025)

7.13.4 VHB Life Sciences Hydroxycarbamide Product Offerings

7.13.5 VHB Life Sciences Recent Development

8 Industry Chain Analysis

8.1 Hydroxycarbamide Industrial Chain

8.2 Hydroxycarbamide Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.2.3 Manufacturing Cost Structure

8.3 Midstream Analysis

8.4 Downstream Analysis (Customers Analysis)

8.5 Sales Model and Sales Channels

8.5.1 Hydroxycarbamide Sales Model

8.5.2 Sales Channel

8.5.3 Hydroxycarbamide Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.1.1 Research Programs/Design

10.1.1.2 Market Size Estimation

10.1.1.3 Market Breakdown and Data Triangulation

10.1.2 Data Source

10.1.2.1 Secondary Sources

10.1.2.2 Primary Sources

10.2 Author Details

10.3 Disclaimer

FEATURED COMPANIES

Bristol–Myers Squibb

Taj Pharma

Beijing Jialin Pharma

Qilu Pharmaceutical

Teva Pharma

Cipla Ltd

Zydus Cadila

United Biotech

Par Pharma

Khandelwal Laboratories

Alkem (Cytomed)

Samarth Pharma

VHB Life Sciences

List of Tables

Table 1. Hydroxycarbamide Market Trends

Table 2. Hydroxycarbamide Market Drivers & Opportunity

Table 3. Hydroxycarbamide Market Challenges

Table 4. Hydroxycarbamide Market Restraints

Table 5. Global Hydroxycarbamide Revenue by Company (2020-2025) & (US$ Million)

Table 6. Global Hydroxycarbamide Revenue Market Share by Company (2020-2025)

Table 7. Global Hydroxycarbamide Sales Volume by Company (2020-2025) & (M Units)

Table 8. Global Hydroxycarbamide Sales Volume Market Share by Company (2020-2025)

Table 9. Global Market Hydroxycarbamide Price by Company (2020-2025) & (USD/K Unit)

Table 10. Key Manufacturers Hydroxycarbamide Manufacturing Base and Headquarters

Table 11. Key Manufacturers Hydroxycarbamide Product Type

Table 12. Key Manufacturers Time to Begin Mass Production of Hydroxycarbamide

Table 13. Global Hydroxycarbamide Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hydroxycarbamide as of 2024)

Table 15. Mergers & Acquisitions, Expansion Plans

Table 16. Global Hydroxycarbamide Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)

Table 17. Global Hydroxycarbamide Sales Value by Type (2020-2025) & (US$ Million)

Table 18. Global Hydroxycarbamide Sales Value by Type (2026-2031) & (US$ Million)

Table 19. Global Hydroxycarbamide Sales Market Share in Value by Type (2020-2025)

Table 20. Global Hydroxycarbamide Sales Market Share in Value by Type (2026-2031)

Table 21. Global Hydroxycarbamide Sales Volume by Type: 2020 VS 2024 VS 2031 (M Units)

Table 22. Global Hydroxycarbamide Sales Volume by Type (2020-2025) & (M Units)

Table 23. Global Hydroxycarbamide Sales Volume by Type (2026-2031) & (M Units)

Table 24. Global Hydroxycarbamide Sales Market Share in Volume by Type (2020-2025)

Table 25. Global Hydroxycarbamide Sales Market Share in Volume by Type (2026-2031)

Table 26. Global Hydroxycarbamide Price by Type (2020-2025) & (USD/K Unit)

Table 27. Global Hydroxycarbamide Price by Type (2026-2031) & (USD/K Unit)

Table 28. Global Hydroxycarbamide Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)

Table 29. Global Hydroxycarbamide Sales Value by Application (2020-2025) & (US$ Million)

Table 30. Global Hydroxycarbamide Sales Value by Application (2026-2031) & (US$ Million)

Table 31. Global Hydroxycarbamide Sales Market Share in Value by Application (2020-2025)

Table 32. Global Hydroxycarbamide Sales Market Share in Value by Application (2026-2031)

Table 33. Global Hydroxycarbamide Sales Volume by Application: 2020 VS 2024 VS 2031 (M Units)

Table 34. Global Hydroxycarbamide Sales Volume by Application (2020-2025) & (M Units)

Table 35. Global Hydroxycarbamide Sales Volume by Application (2026-2031) & (M Units)

Table 36. Global Hydroxycarbamide Sales Market Share in Volume by Application (2020-2025)

Table 37. Global Hydroxycarbamide Sales Market Share in Volume by Application (2026-2031)

Table 38. Global Hydroxycarbamide Price by Application (2020-2025) & (USD/K Unit)

Table 39. Global Hydroxycarbamide Price by Application (2026-2031) & (USD/K Unit)

Table 40. Global Hydroxycarbamide Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)

Table 41. Global Hydroxycarbamide Sales Value by Region (2020-2025) & (US$ Million)

Table 42. Global Hydroxycarbamide Sales Value by Region (2026-2031) & (US$ Million)

Table 43. Global Hydroxycarbamide Sales Value by Region (2020-2025) & (%)

Table 44. Global Hydroxycarbamide Sales Value by Region (2026-2031) & (%)

Table 45. Global Hydroxycarbamide Sales Volume by Region (M Units): 2020 VS 2024 VS 2031

Table 46. Global Hydroxycarbamide Sales Volume by Region (2020-2025) & (M Units)

Table 47. Global Hydroxycarbamide Sales Volume by Region (2026-2031) & (M Units)

Table 48. Global Hydroxycarbamide Sales Volume by Region (2020-2025) & (%)

Table 49. Global Hydroxycarbamide Sales Volume by Region (2026-2031) & (%)

Table 50. Global Hydroxycarbamide Average Price by Region (2020-2025) & (USD/K Unit)

Table 51. Global Hydroxycarbamide Average Price by Region (2026-2031) & (USD/K Unit)

Table 52. Key Countries/Regions Hydroxycarbamide Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031

Table 53. Key Countries/Regions Hydroxycarbamide Sales Value, (2020-2025) & (US$ Million)

Table 54. Key Countries/Regions Hydroxycarbamide Sales Value, (2026-2031) & (US$ Million)

Table 55. Key Countries/Regions Hydroxycarbamide Sales Volume, (2020-2025) & (M Units)

Table 56. Key Countries/Regions Hydroxycarbamide Sales Volume, (2026-2031) & (M Units)

Table 57. Bristol Myers Squibb Company Information

Table 58. Bristol Myers Squibb Introduction and Business Overview

Table 59. Bristol Myers Squibb Hydroxycarbamide Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2020-2025)

Table 60. Bristol Myers Squibb Hydroxycarbamide Product Offerings

Table 61. Bristol Myers Squibb Recent Development

Table 62. Taj Pharma Company Information

Table 63. Taj Pharma Introduction and Business Overview

Table 64. Taj Pharma Hydroxycarbamide Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2020-2025)

Table 65. Taj Pharma Hydroxycarbamide Product Offerings

Table 66. Taj Pharma Recent Development

Table 67. Beijing Jialin Pharma Company Information

Table 68. Beijing Jialin Pharma Introduction and Business Overview

Table 69. Beijing Jialin Pharma Hydroxycarbamide Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2020-2025)

Table 70. Beijing Jialin Pharma Hydroxycarbamide Product Offerings

Table 71. Beijing Jialin Pharma Recent Development

Table 72. Qilu Pharmaceutical Company Information

Table 73. Qilu Pharmaceutical Introduction and Business Overview

Table 74. Qilu Pharmaceutical Hydroxycarbamide Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2020-2025)

Table 75. Qilu Pharmaceutical Hydroxycarbamide Product Offerings

Table 76. Qilu Pharmaceutical Recent Development

Table 77. Teva Pharma Company Information

Table 78. Teva Pharma Introduction and Business Overview

Table 79. Teva Pharma Hydroxycarbamide Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2020-2025)

Table 80. Teva Pharma Hydroxycarbamide Product Offerings

Table 81. Teva Pharma Recent Development

Table 82. Cipla Company Information

Table 83. Cipla Introduction and Business Overview

Table 84. Cipla Hydroxycarbamide Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2020-2025)

Table 85. Cipla Hydroxycarbamide Product Offerings

Table 86. Cipla Recent Development

Table 87. Zydus Cadila Company Information

Table 88. Zydus Cadila Introduction and Business Overview

Table 89. Zydus Cadila Hydroxycarbamide Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2020-2025)

Table 90. Zydus Cadila Hydroxycarbamide Product Offerings

Table 91. Zydus Cadila Recent Development

Table 92. United Biotech Company Information

Table 93. United Biotech Introduction and Business Overview

Table 94. United Biotech Hydroxycarbamide Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2020-2025)

Table 95. United Biotech Hydroxycarbamide Product Offerings

Table 96. United Biotech Recent Development

Table 97. Par Pharma Company Information

Table 98. Par Pharma Introduction and Business Overview

Table 99. Par Pharma Hydroxycarbamide Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2020-2025)

Table 100. Par Pharma Hydroxycarbamide Product Offerings

Table 101. Par Pharma Recent Development

Table 102. Khandelwal Laboratories Company Information

Table 103. Khandelwal Laboratories Introduction and Business Overview

Table 104. Khandelwal Laboratories Hydroxycarbamide Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2020-2025)

Table 105. Khandelwal Laboratories Hydroxycarbamide Product Offerings

Table 106. Khandelwal Laboratories Recent Development

Table 107. Alkem (Cytomed) Company Information

Table 108. Alkem (Cytomed) Introduction and Business Overview

Table 109. Alkem (Cytomed) Hydroxycarbamide Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2020-2025)

Table 110. Alkem (Cytomed) Hydroxycarbamide Product Offerings

Table 111. Alkem (Cytomed) Recent Development

Table 112. Samarth Pharma Company Information

Table 113. Samarth Pharma Introduction and Business Overview

Table 114. Samarth Pharma Hydroxycarbamide Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2020-2025)

Table 115. Samarth Pharma Hydroxycarbamide Product Offerings

Table 116. Samarth Pharma Recent Development

Table 117. VHB Life Sciences Company Information

Table 118. VHB Life Sciences Introduction and Business Overview

Table 119. VHB Life Sciences Hydroxycarbamide Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2020-2025)

Table 120. VHB Life Sciences Hydroxycarbamide Product Offerings

Table 121. VHB Life Sciences Recent Development

Table 122. Key Raw Materials Lists

Table 123. Raw Materials Key Suppliers Lists

Table 124. Hydroxycarbamide Downstream Customers

Table 125. Hydroxycarbamide Distributors List

Table 126. Research Programs/Design for This Report

Table 127. Key Data Information from Secondary Sources

Table 128. Key Data Information from Primary Sources

List of Figures

Figure 1. Hydroxycarbamide Product Picture

Figure 2. Global Hydroxycarbamide Sales Value, 2020 VS 2024 VS 2031 (US$ Million)

Figure 3. Global Hydroxycarbamide Sales Value (2020-2031) & (US$ Million)

Figure 4. Global Hydroxycarbamide Sales Volume (2020-2031) & (M Units)

Figure 5. Global Hydroxycarbamide Sales Price (2020-2031) & (USD/K Unit)

Figure 6. Hydroxycarbamide Report Years Considered

Figure 7. Global Hydroxycarbamide Players Revenue Ranking (2024) & (US$ Million)

Figure 8. Global Hydroxycarbamide Players Sales Volume Ranking (2024) & (M Units)

Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Hydroxycarbamide Revenue in 2024

Figure 10. Hydroxycarbamide Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 11. Capsule Picture

Figure 12. Tablet Picture

Figure 13. Global Hydroxycarbamide Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)

Figure 14. Global Hydroxycarbamide Sales Value Market Share by Type, 2024 & 2031

Figure 15. Global Hydroxycarbamide Sales Volume by Type (2020 VS 2024 VS 2031) & (M Units)

Figure 16. Global Hydroxycarbamide Sales Volume Market Share by Type, 2024 & 2031

Figure 17. Global Hydroxycarbamide Price by Type (2020-2031) & (USD/K Unit)

Figure 18. Product Picture of Sickle Cell Disease

Figure 19. Product Picture of Cancer

Figure 20. Product Picture of Others

Figure 21. Global Hydroxycarbamide Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)

Figure 22. Global Hydroxycarbamide Sales Value Market Share by Application, 2024 & 2031

Figure 23. Global Hydroxycarbamide Sales Volume by Application (2020 VS 2024 VS 2031) & (M Units)

Figure 24. Global Hydroxycarbamide Sales Volume Market Share by Application, 2024 & 2031

Figure 25. Global Hydroxycarbamide Price by Application (2020-2031) & (USD/K Unit)

Figure 26. North America Hydroxycarbamide Sales Value (2020-2031) & (US$ Million)

Figure 27. North America Hydroxycarbamide Sales Value by Country (%), 2024 VS 2031

Figure 28. Europe Hydroxycarbamide Sales Value, (2020-2031) & (US$ Million)

Figure 29. Europe Hydroxycarbamide Sales Value by Country (%), 2024 VS 2031

Figure 30. Asia Pacific Hydroxycarbamide Sales Value, (2020-2031) & (US$ Million)

Figure 31. Asia Pacific Hydroxycarbamide Sales Value by Region (%), 2024 VS 2031

Figure 32. South America Hydroxycarbamide Sales Value, (2020-2031) & (US$ Million)

Figure 33. South America Hydroxycarbamide Sales Value by Country (%), 2024 VS 2031

Figure 34. Middle East & Africa Hydroxycarbamide Sales Value, (2020-2031) & (US$ Million)

Figure 35. Middle East & Africa Hydroxycarbamide Sales Value by Country (%), 2024 VS 2031

Figure 36. Key Countries/Regions Hydroxycarbamide Sales Value (%), (2020-2031)

Figure 37. Key Countries/Regions Hydroxycarbamide Sales Volume (%), (2020-2031)

Figure 38. United States Hydroxycarbamide Sales Value, (2020-2031) & (US$ Million)

Figure 39. United States Hydroxycarbamide Sales Value by Type (%), 2024 VS 2031

Figure 40. United States Hydroxycarbamide Sales Value by Application (%), 2024 VS 2031

Figure 41. Europe Hydroxycarbamide Sales Value, (2020-2031) & (US$ Million)

Figure 42. Europe Hydroxycarbamide Sales Value by Type (%), 2024 VS 2031

Figure 43. Europe Hydroxycarbamide Sales Value by Application (%), 2024 VS 2031

Figure 44. China Hydroxycarbamide Sales Value, (2020-2031) & (US$ Million)

Figure 45. China Hydroxycarbamide Sales Value by Type (%), 2024 VS 2031

Figure 46. China Hydroxycarbamide Sales Value by Application (%), 2024 VS 2031

Figure 47. Japan Hydroxycarbamide Sales Value, (2020-2031) & (US$ Million)

Figure 48. Japan Hydroxycarbamide Sales Value by Type (%), 2024 VS 2031

Figure 49. Japan Hydroxycarbamide Sales Value by Application (%), 2024 VS 2031

Figure 50. South Korea Hydroxycarbamide Sales Value, (2020-2031) & (US$ Million)

Figure 51. South Korea Hydroxycarbamide Sales Value by Type (%), 2024 VS 2031

Figure 52. South Korea Hydroxycarbamide Sales Value by Application (%), 2024 VS 2031

Figure 53. Southeast Asia Hydroxycarbamide Sales Value, (2020-2031) & (US$ Million)

Figure 54. Southeast Asia Hydroxycarbamide Sales Value by Type (%), 2024 VS 2031

Figure 55. Southeast Asia Hydroxycarbamide Sales Value by Application (%), 2024 VS 2031

Figure 56. India Hydroxycarbamide Sales Value, (2020-2031) & (US$ Million)

Figure 57. India Hydroxycarbamide Sales Value by Type (%), 2024 VS 2031

Figure 58. India Hydroxycarbamide Sales Value by Application (%), 2024 VS 2031

Figure 59. Hydroxycarbamide Industrial Chain

Figure 60. Hydroxycarbamide Manufacturing Cost Structure

Figure 61. Channels of Distribution (Direct Sales, and Distribution)

Figure 62. Bottom-up and Top-down Approaches for This Report

Figure 63. Data Triangulation

Figure 64. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$3950

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Hydroxyurea Market Research Report 2025

Global Vincristine Market Research Report 2024

Global N Nitroso N methylurea Market Insights Forecast to 2030

Global Vinorelbine Market Research Report 2024

Global Adenosylcobalamin Tablets Market Research Report 2024

Hemoglobinopathy Treatment Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Neuroblastoma Chemotherapy Drugs Market Research Report 2025

Chlorambucil Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Sickle cell Anemia Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Hydroxyurea Tablets Market Research Report 2024

Global Procarbazine Market Research Report 2025

Global Cobamamide for Injection Market Research Report 2024

Global Hydroxychloroquine Market Research Report 2024

Global Hydroxyurea API Market Research Report 2024

Cobamamide Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Hemoglobinopathy Drugs Market Insights Forecast to 2030

Global Hemoglobinopathies Drugs Market Research Report 2024

Global Iron Drugs Market Research Report 2024

Global Polycythemia Vera Treatment Drugs Market Research Report 2025

RELATED REPORTS

Global Hormonal Therapy for Cancer Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-5L19798

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Cancer Insurance Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-28I6901

Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Induced Myeloid Leukemia Cell Differentiation Protein Mcl 1 Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-22R9736

Wed Sep 10 00:00:00 UTC 2025

Add to Cart

Global Drugs for Differentiated Thyroid Cancer Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-29A2598

Tue Sep 09 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions